Therapeutic Antibodies

Therapeutic Antibodies
Author : Antony S. Dimitrov
Publisher : Humana Press
Total Pages : 585
Release : 2014-11-25
ISBN 10 : 1627038698
ISBN 13 : 9781627038690
Language : EN, FR, DE, ES & NL

Therapeutic Antibodies Book Description:

Over 2000 years ago in China, antibodies elicited by early forms of vaccination likely played a major role in the protection of the population from infectious agents. Vac- nation has been further developed in Europe and described by Edward Jenner in the late-eighteenth century, then successfully implemented worldwide. The idea to use theactiveingredientinthebloodofvaccinated(orimmunized)animalsorhumansfor the treatment of diseases came a century later. It was made possible by a series of discoveries,suchastherealizationthattheserumfromanimalsimmunizedwithtoxins, for example, diphtheria toxin or viruses, is an effective therapeutic against the disease causedbythesameagentinhumans. Inthe1880s,vonBehringdevelopedanantitoxin (anti-body) that did not kill the bacteria but neutralized the bacterial toxin. The first Nobel Prize in Medicine (1901) was given to him for the discovery of the serum therapy. Acenturylater,22monoclonalantibodies(mAbs)areapprovedbytheUnited States Food and Drug Administration (FDA) for clinical use, and hundreds are in clinicaltrialsforthetreatmentofvariousdiseasesincludingcancers,immunedisorders, and infections. The revenues from the top-five therapeutic antibodies reached $11. 7 billion in 2006, and major pharmaceutical companies raced to acquire antibody biotech companies with a recent example of MedImmune, Inc. , which was acquired for $15. 6 billion by AstraZeneca in 2007. This explosion of research and development in the field of therapeutic antibodies prompted the publication of the MiMB volume Therapeutic Antibodies: Methods and Protocols. The book’s major goal is to present a set of protocols useful for researchers discoveringanddevelopingtherapeuticantibodies. Currentadvancesandfuturetrends in the antibody therapeutics are analyzed in the lead-in review article.


RELATED BOOKS:
Therapeutic Antibodies
Language: en
Pages: 585
Authors: Antony S. Dimitrov
Categories: Medical
Type: BOOK - Published: 2014-11-25 - Publisher: Humana Press

Over 2000 years ago in China, antibodies elicited by early forms of vaccination likely played a major role in the protection of the population from infectious agents. Vac- nation has been further developed in Europe and described by Edward Jenner in the late-eighteenth century, then successfully implemented worldwide. The idea
Therapeutic Antibodies
Language: en
Pages: 380
Authors: Yuti Chernajovsky, Ahuva Nissim
Categories: Medical
Type: BOOK - Published: 2007-12-11 - Publisher: Springer Science & Business Media

This essential work, edited by two researchers at London’s famous Queen Mary’s medical school targets one of the most important areas in medical development today. These days, antibody therapeutics are the treatment of choice for several autoimmune and oncological conditions. They are, indeed, becoming the molecules of choice for further
Diagnostic and Therapeutic Antibodies
Language: en
Pages: 477
Authors: Andrew J. T. George, Catherine E. Urch
Categories: Medical
Type: BOOK - Published: 2000 - Publisher: Springer Science & Business Media

Books about Diagnostic and Therapeutic Antibodies
Therapeutic Antibody Engineering
Language: en
Pages: 696
Authors: William R Strohl, Lila M Strohl
Categories: Science
Type: BOOK - Published: 2012-10-16 - Publisher: Elsevier

The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect
Handbook of Therapeutic Antibodies
Language: en
Pages: 2544
Authors: Stefan Dübel, Janice M. Reichert
Categories: Science
Type: BOOK - Published: 2014-08-04 - Publisher: John Wiley & Sons

Still the most comprehensive reference source on the development, production and therapeutic application of antibodies, this second edition is thoroughly updated and now has 30% more content. Volume 1 covers selection and engineering strategies for new antibodies, while the second volume presents novel therapeutic concepts and antibodies in clinical study,